Kevin A. Lobo
Parker-HannifinAbout Kevin A. Lobo
Kevin A. Lobo, age 60, has served as an independent director of Parker-Hannifin Corporation since 2013. He is Chairman, CEO and President of Stryker Corporation, with prior leadership roles at Johnson & Johnson, and finance roles at KPMG, Unilever, Kraft Canada and Rhone-Poulenc; at Parker he chairs the Audit Committee and sits on the Human Resources & Compensation Committee . The Board has affirmatively determined he is independent; although Stryker has ordinary-course customer/supplier relationships with Parker, amounts are below NYSE and company independence thresholds and he receives no personal benefit from them .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Stryker Corporation | Chairman (since 2014); CEO, President & Director (since 2012) | 2012–present | Enterprise leadership across M&A, product innovation, finance, succession and talent management |
| Johnson & Johnson (incl. Ethicon Endo-Surgery) | Operations leadership roles | 1997–2011 | Strategy, operations and P&L leadership |
| Rhone-Poulenc | Operations leadership roles | 1997–2011 | Operational leadership |
| KPMG; Unilever; Kraft Canada | Finance roles of increasing responsibility | 1987–1997 | Finance, accounting and strategic pricing |
External Roles
| Company | Role | Public company board | Notes |
|---|---|---|---|
| Stryker Corporation (NYSE: SYK) | Chairman; CEO; President; Director | Yes | Current public company directorship since 2012 |
Board Governance
- Committee assignments: Audit Committee Chair and member; Human Resources & Compensation Committee member .
- Independence: Board-determined independent; relationships with Parker are ordinary course, on competitive terms, and below NYSE/company thresholds .
- Attendance and engagement: FY2025 Board held 12 meetings; average director attendance >95%, and each director attended at least 81% of Board/committee meetings; non-management directors met in executive session four times . FY2024 average attendance 97% with at least 80% for each director; non-management directors met four times .
- Lead Independent Director: James L. Wainscott (not Lobo) .
- Audit Committee cadence and oversight: Audit Committee met 5 times in FY2025; Lobo designated as an audit committee financial expert. Oversight includes auditor appointment/independence, financial reporting, internal controls, and risk oversight; private sessions with auditors and VP Audit/ERM at each meeting .
Fixed Compensation
| Component | FY2024 | FY2025 |
|---|---|---|
| Cash retainer (Audit Chair) | $175,564 | $185,000 |
| Committee chair/member retainers (program levels) | Audit Chair $185,000; HRC Chair $185,000; Lead Director $230,000; Members $155,000 | Audit Chair $185,000; HRC Chair $185,000; Lead Director $230,000; Members $155,000; increase effective Oct 22, 2025: +$5,000 retainer |
| Total cash paid to Lobo | $175,564 | $185,000 |
Notes:
- Meeting fees: $2,000 per meeting beyond two above regularly scheduled; Lobo had no incremental meeting fees disclosed in FY2024 or FY2025 .
- Program changes: HRC approved +$5,000 annual retainer effective Oct 22, 2025 .
Performance Compensation
| Equity Award | Grant date | Shares/Units | Grant date fair value | Vesting schedule |
|---|---|---|---|---|
| Director RSUs (annual grant) | Oct 25, 2023 | 453 RSUs | $166,487 | 100% on later of one year from grant or next Annual Meeting; dividend equivalents accrue as RSUs |
| Director RSUs (annual grant) | Oct 23, 2024 | 299 RSUs | $188,280 | 100% on later of one year from grant or next Annual Meeting; dividend equivalents accrue as RSUs |
| Program changes | Aug 11, 2025 | — | +$15,000 increase in target equity awards (effective Oct 22, 2025) | Applies prospectively to non-employee directors |
No options/SARs are held by non-employee directors, including Lobo .
Other Directorships & Interlocks
| External company | Role | Relationship to Parker | Governance determination |
|---|---|---|---|
| Stryker Corporation | Chairman, CEO, President | Existing customer/supplier relationships evaluated by Board | Ordinary-course, competitive terms; amounts below NYSE/company thresholds; Lobo receives no personal benefit; independence affirmed |
Expertise & Qualifications
- Public company leadership; finance & accounting; corporate strategy & culture; risk management; international experience .
- Audit Committee financial expertise designation .
Equity Ownership
| Item | Amount |
|---|---|
| Beneficial ownership (common shares) | 7,313 shares |
| RSUs held (as of Jun 30, 2025) | 299 RSUs |
| Options/SARs held | None |
| Ownership as % of shares outstanding | ~0.0058% (7,313 / 126,544,072) |
| Stock ownership guideline for non-management directors | 5× annual retainer |
| Compliance status | All directors in role ≥5 years were compliant as of Jun 30, 2025 (Lobo joined in 2013) |
| Hedging/pledging | Prohibited for directors and officers under insider trading policy |
Insider Trades
| Period checked | Person | Result |
|---|---|---|
| 2023-01-01 to 2025-11-20 | Kevin A. Lobo (PH) | No Form 4 insider trades found (Insider-Trades skill run on 2025-11-20) |
Governance Assessment
- Strengths: Independent Audit Committee Chair with ACFE designation; strong attendance culture; robust clawback policy compliant with NYSE/SEC; anti-hedging/pledging; director ownership guidelines with confirmed compliance; clear committee oversight of risk and governance .
- Potential conflicts: Executive role at Stryker with ordinary-course relationships to Parker; Board reviewed amounts/terms and affirmed independence—no related-party transactions requiring disclosure in FY2025 .
- Pay signals: Director pay is balanced between cash retainer and time-based RSUs; program modestly increased retainer/equity in 2025, consistent with market ; no performance metrics linked to director compensation (RSUs time-based) .
- Shareholder feedback: Say-on-Pay approval ~89% at 2024 Annual Meeting indicates supportive compensation governance backdrop . Peer group used for compensation benchmarking includes leading diversified industrials (e.g., 3M, Caterpillar, Eaton, Honeywell, Rockwell) .
Red flags: None material identified—no pledging/hedging, no related-party transactions requiring approval, independence affirmed despite external leadership role, and strong attendance and committee governance practices .